The skirmish between Chinese and Indian troops over a long-disputed border this month is being treated in New Delhi as the country's worst diplomatic crisis in decades even as it is downplayed by Beijing.
BEIJING/NEW DELHI - The skirmish between Chinese and Indian troops over a long-disputed border this month is being treated in New Delhi as the country’s worst diplomatic crisis in decades even as it is downplayed by Beijing.
The two sides were working to ease tensions, China’s foreign ministry said on Tuesday. Chinese media coverage has been scant. Since the deaths of 20 Indian soldiers in hand-to-hand fighting in the Galwan Valley, in the worst combat losses on the de facto border with China in more than 50 years, Indian Prime Minister Narendra Modi, a strident nationalist, has faced heated calls for a strong response.“Indians watch everything that China is doing, but most Chinese only have eyes for international issues related to the U.S.
“This area is a barren hilltop with no economic or geostrategic value. From the Chinese government point of view, it is not worth destabilising bilateral relations over this,” said Zhang.PRESSURE DIFFERENTIAL
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
After China Border Fight, India Likely Weighs Closer U.S. Military TiesFaced with an increasingly assertive and well-armed China, Indian policy makers are likely considering whether to further expand military cooperation with the U.S. and American allies.
Lire la suite »
India and China have their first deadly clashes in 45 yearsBloodshed on the border marks a turning point in relations between Asia’s giants
Lire la suite »
A Teenager Who Cycled Her Father Across India Gets An Offer To Train For The OlympicsBroke and hungry, an Indian teenager has put her ill father on the back of her bicycle and pedaled hundreds of miles to their home village. Now, she got an offer to train for the Olympics.
Lire la suite »
India gives Hetero Labs approval to make Gilead's COVID-19 drugIndia's drug regulator has given Hetero Labs the green light to manufacture and market its generic version of Gilead Science's experimental COVID-19 treatment remdesivir, the Indian pharmaceutical company said on Sunday.
Lire la suite »
India gives Hetero Labs and Cipla approval to make Gilead's COVID-19 drugIndia's drug regulator has given Hetero Labs and Cipla Ltd the green light to manufacture and market their generic version of Gilead Sciences Inc's experimental COVID-19 treatment remdesivir, the Indian pharmaceutical companies said on Sunday.
Lire la suite »